-

Shareholder Alert: Robbins LLP Reminds Investors It Is Investigating the Officers and Directors of Casper Sleep Inc. (CSPR) on Behalf of Shareholders

SAN DIEGO & NEW YORK--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors it is investigating Casper Sleep Inc. (NYSE: CSPR) for potential violations of federal securities laws pursuant to its February 2020 initial public offering ("IPO"). Casper designs and sells sleep products to consumers in the United States, Canada, and Europe.

If you purchased shares of Casper stock, click here.

Casper Sleep Inc. (CSPR) Reports Disappointing First Quarter 2020 Financials

On February 6, 2020, Casper completed its IPO offering 8.35 million shares of common stock at $12.00 per share and raising $88 million in net proceeds. In its Registration Statement, Casper assured investors that "[o]verall business profitability will be driven" by "continued net revenue growth," "gross margin improvements," and operational efficiencies. Then, on April 21, 2020, Casper announced it was taking significant actions to improve its cash position and business model, including downsizing its global operations and sales team totaling a 21% loss in workforce. That same day, the Company also revealed the resignation of its CFO and COO. Finally, on May 12, 2020, Casper announced its first quarter 2020 financial results, which revealed a net loss of $34.5 million and an adjusted EBITDA loss of $22.9 million, representing year-over-year increases of almost 98% and 60% respectively. Since the IPO, Casper stock consistently trades well below the IPO price, currently trading at around $9, representing a decline of 25% from its IPO price.

Casper Sleep Inc. (CSPR) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
LKandinov@robbinsllp.com
Shareholder Information Form

Want to be notified if a class action against Casper settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leonid Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NYSE:CSPR
Release Versions
English
$Cashtags
$CSPR
Hashtags
#ClassAction
#Finance
#Investment
#Investor
#Lawsuit
#Securities
#Shareholder
#Shareholderrights
#StockAlert
#StockMarketData
#StockNews
#StockTrading
#Stocks
#Trader
#shareholderrightslawfirm

Contacts

Leonid Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Notice: Robbins LLP Informs Investors of the Super Micro Computer, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Super Micro Computer, Inc. (NASDAQ: SMCI) securities between April 30, 2024 and March 19, 2026. Super Micro is a technology company that designs, develops, and manufactures high-performance server and storage systems, primarily for artificial intelligence (“AI”), data center, and cloud solutions customers. For more information, submit a form,...

BlackRock TCP Capital Corp. Investor Alert - TCPC Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired BlackRock TCP Capital Corp. (NASDAQ: TCPC) securities between November 6, 2024 and January 23, 2026. BlackRock TCP is a business development company that raises funds from investors and then uses those funds to make loans to small and midsize businesses as an alternative to bank financing. For more information, submit a form, email attorney Aa...

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASDAQ: MREO) American Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on the development of therapeutics for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the alleg...
Back to Newsroom